Table 3 Prognostic factor analysis of progression-free survival time
Parameter | Median progression-free survival time (months) (95% CI) | P-value | |
|---|---|---|---|
XELIRI (n=30) | IRI (n=30) | ||
Tumour site | |||
Gallbladder | 2.3 (1.3, 3.3) | 2.8 (1.9, 3.7) | 0.689 |
Non-gallbladder | 4.9 (0.7, 9.1) | 2.4 (1.8, 3.0) | 0.032* |
CA 19-9 | |||
≥400 IU/ml | 2.3 (0.1, 5.0) | 2.4 (0.5, 4.3) | 0.341 |
<400 IU/ml | 4.3 (0.1, 9.6) | 2.8 (2.4, 3.2) | 0.022* |
Age | |||
≥60 | 2.6 (0.1, 7.0) | 2.4 (1.8, 3.0) | 0.079 |
<60 | 2.0 (0.1, 5.7) | 2.4 (1.7, 3.1) | 0.124 |
Extent of disease | |||
Locally advanced | 2.2 (0.9, 3.5) | 2.4 (1.7, 3.1) | 0.203 |
Metastatic | 3.7 (0.1, 7.6) | 2.4 (2.2, 2.6) | 0.053 |
